Dr. Scirica and colleagues reply

New England Journal of Medicine

Volumn 370, Issue 5, 2014, Pages 483-484

  Scirica, Benjamin M ^a   Braunwald, Eugene ^a   Bhatt, Deepak L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATRIURETIC FACTOR; SAXAGLIPTIN; ADAMANTANE; ANTIDIABETIC AGENT; DIPEPTIDE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DRUG DERIVATIVE;

BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS; FEMALE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE;

ADAMANTANE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIPEPTIDES; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE;

EID: 84893116807     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1313880     Document Type: Letter

References (1)

1. Scirica BM, Raz I, Cavender MA, et al. Outcomes of patients with type 2 diabetes and known congestive heart failure treated with saxagliptin: analyses of the SAVOR-TIMI 53 Study. Circulation 2013;128:A17503. abstract.